These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
456 related items for PubMed ID: 9180855
1. [Tamoxifen adjuvant delays early breast cancer. Results of a cooperative randomized trial]. Delozier T, Switsers O, Génot JY, Ollivier JM, Héry M, Namer M, Frenay M, Kerbrat P, Julien JP, Naja A, Janvier M, Macé-Lesec'h J. Bull Cancer; 1997 Jan; 84(1):25-30. PubMed ID: 9180855 [Abstract] [Full Text] [Related]
2. Benefit and projected cost-effectiveness of anastrozole versus tamoxifen as initial adjuvant therapy for patients with early-stage estrogen receptor-positive breast cancer. Hillner BE. Cancer; 2004 Sep 15; 101(6):1311-22. PubMed ID: 15368322 [Abstract] [Full Text] [Related]
3. Postoperative adjuvant chemotherapy followed by adjuvant tamoxifen versus nil for patients with operable breast cancer: a randomised phase III trial of the European Organisation for Research and Treatment of Cancer Breast Group. Morales L, Canney P, Dyczka J, Rutgers E, Coleman R, Cufer T, Welnicka-Jaskiewicz M, Nortier J, Bogaerts J, Therasse P, Paridaens R, European Organisation for Research and Treatment of Cancer Breast Group, Scottish Breast Cancer Trials Group. Eur J Cancer; 2007 Jan 15; 43(2):331-40. PubMed ID: 17134892 [Abstract] [Full Text] [Related]
8. Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975-1999. Mariotto AB, Feuer EJ, Harlan LC, Abrams J. J Natl Cancer Inst Monogr; 2006 Jan 15; (36):7-15. PubMed ID: 17032888 [Abstract] [Full Text] [Related]
11. Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of International Breast Cancer Study Group Trial 10-93. International Breast Cancer Study GroupWest Swedish Breast Cancer Study Group, Sahlgrenska University Hospital/Mölndal, Göteborgsvägen 31, 431 80 Mölndal, Sweden. c-m.rudenstam@telia.com, Rudenstam CM, Zahrieh D, Forbes JF, Crivellari D, Holmberg SB, Rey P, Dent D, Campbell I, Bernhard J, Price KN, Castiglione-Gertsch M, Goldhirsch A, Gelber RD, Coates AS. J Clin Oncol; 2006 Jan 20; 24(3):337-44. PubMed ID: 16344321 [Abstract] [Full Text] [Related]
12. Postoperative adjuvant therapy with tamoxifen, tegafur plus uracil, or both in women with node-negative breast cancer: a pooled analysis of six randomized controlled trials. Noguchi S, Koyama H, Uchino J, Abe R, Miura S, Sugimachi K, Akazawa K, Abe O. J Clin Oncol; 2005 Apr 01; 23(10):2172-84. PubMed ID: 15800310 [Abstract] [Full Text] [Related]
16. The use of early adjuvant aromatase inhibitor therapy: contributions from the BIG 1-98 letrozole trial. Forbes JF. Semin Oncol; 2006 Apr 01; 33(2 Suppl 7):S2-7. PubMed ID: 16730270 [Abstract] [Full Text] [Related]
20. Long-term follow-up of the randomized Stockholm trial on adjuvant tamoxifen among postmenopausal patients with early stage breast cancer. Rutqvist LE, Johansson H, Stockholm Breast Cancer Study Group. Acta Oncol; 2007 Apr 01; 46(2):133-45. PubMed ID: 17453361 [Abstract] [Full Text] [Related] Page: [Next] [New Search]